Indiva Limited engages in the production, processing, and sale of cannabis and cannabis related products in Canada. It offers edibles, capsules and tablets, and vape products under the No Future, Pearls by gron, Bhang Chocolate, Indiva Doppio, Indiva Blips, and Indiva 1432 brands. Indiva Limited is based in Ottawa, Canada.
Research context
Indiva Limited appears in PyInvesting’s TSX Venture Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CAD
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Indiva Limited is currently in a long term downtrend where the price is trading 7.4% below its 200 day moving average.
From a valuation standpoint, the stock is 99.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 5.6.
Indiva Limited's total revenue rose by 1531.6% to $3M since the same quarter in the previous year.
Its net income has dropped by 36.0% to $-4M since the same quarter in the previous year.
Finally, its free cash flow fell by 56.6% to $-5M since the same quarter in the previous year.
Based on the above factors, Indiva Limited gets an overall score of 2/5.